1999
DOI: 10.1016/s0959-8049(99)81079-x
|View full text |Cite
|
Sign up to set email alerts
|

Phase II studies using electroporation therapy in patients with recurrent head and neck cancer: a safe and active treatment approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2001
2001
2016
2016

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Lastly, a recent cross‐institutional collaborative study was presented in which intralesional bleomycin with and without concomitant electroporation was used. 20 In trial no. 1, intralesional bleomycin was used alone, and it did not have any complete or even partial responses (0 of 32 lesions).…”
Section: Discussionmentioning
confidence: 99%
“…Lastly, a recent cross‐institutional collaborative study was presented in which intralesional bleomycin with and without concomitant electroporation was used. 20 In trial no. 1, intralesional bleomycin was used alone, and it did not have any complete or even partial responses (0 of 32 lesions).…”
Section: Discussionmentioning
confidence: 99%